Drp1 peptide inhibitor P110

2770267-63-3

L-Serinamide, L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginylglycylglycyl-L-α-aspartyl-L-leucyl-L-leucyl-L-prolyl-L-arginylglycyl-; (3S,12S,15S,18S,21S,24S,27S,30S,33S,36S,42S)-42-amino-3-(((S)-1-(((S)-1-((S)-2-(((S)-1-((2-(((S)-1-amino-3-hydroxy-1-oxopropan-2-yl)amino)-2-oxoethyl)amino)-5-guanidino-1-oxopentan-2-yl)carbamoyl)pyrrolidin-1-yl)-4-methyl-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)-21-(3-amino-3-oxopropyl)-30,33-bis(4-aminobutyl)-12,15,18,24,27,36-hexakis(3-guanidinopropyl)-43-(4-hydroxyphenyl)-5,8,11,14,17,20,23,26,29,32,35,38,41-tridecaoxo-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaazatritetracontanoic Acid; Dynamic-related protein 1 (Drp-1)-specific inhibitor P110;